PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Harvard Radiation Oncology Program, Harvard University, Boston, Massachusetts, USA.\', \'Department of Radiation Oncology, Brigham and Women\'s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.\', \'Division of Infectious Diseases, Department of Medicine, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Harvard University, Boston, Massachusetts, USA.\', \'Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cncr.32962
?:doi
?:hasPublicationType
?:journal
  • Cancer
is ?:pmid of
?:pmid
?:pmid
  • 32463478
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.455
?:rankingScore_hIndex
  • 265
?:title
  • Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32463478>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32463478>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all